Home › Funds › Point72 Asset Management › XENE
Point72 Asset Management position in XENE
XENON PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)130.38K sh
Reported value held$7.87M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.08M | $16.47M | New |
| Q4 2021 | 2.99M | $93.49M | Add |
| Q1 2022 | 2.15M | $65.62M | Reduce |
| Q2 2022 | 901.51K | $27.42M | Reduce |
| Q3 2022 | 1.64M | $59.21M | Add |
| Q4 2022 | 1.18M | $46.46M | Reduce |
| Q1 2023 | 504.62K | $18.06M | Reduce |
| Q2 2023 | 148.21K | $5.71M | Reduce |
| Q3 2023 | 1.13M | $38.45M | Add |
| Q4 2023 | 875.07K | $40.31M | Reduce |
| Q1 2024 | 275.86K | $11.88M | Reduce |
| Q2 2024 | 482.02K | $18.79M | Add |
| Q3 2024 | 383.29K | $15.09M | Reduce |
| Q1 2025 | 209.76K | $7.04M | New |
| Q1 2025 | 209.76K | $7.04M | New |
| Q4 2025 | 18.60K | $833.65K | New |
| Q1 2026 | 18.60K | $1.08M | Hold |
| Q2 2026 | 130.38K | $7.87M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding XENE
- Fidelity Management & Research (FMR) 9.65M sh · $582.35M · Q2 2026
- BlackRock Inc 7.52M sh · $454.06M · Q2 2026
- Janus Henderson Group 4.18M sh · $242.86M · Q1 2026
- JPMorgan Chase & Co 2.62M sh · $157.38M · Q2 2026
- Two Sigma Investments 1.64M sh · $99.16M · Q2 2026
- Franklin Resources 1.44M sh · $86.78M · Q2 2026
- Wellington Management Group 1.43M sh · $86.04M · Q2 2026
- Geode Capital Management 1.37M sh · $82.69M · Q2 2026
- Invesco Ltd 903.46K sh · $54.53M · Q2 2026
- Capital World Investors 862.77K sh · $52.08M · Q2 2026
- Goldman Sachs Group 773.62K sh · $46.70M · Q2 2026
- Marshall Wace 689.34K sh · $41.61M · Q2 2026